Document:

THIS AGREEMENT is made the     10th   day of January 2003

PARTIES:

(1)	Dr Boris Gorbunov of 20 Kings Park, Canterbury, Kent CT1 1QH
("Dr Gorbunov"),

(2)	Atlantic Security Inc (incorporated in the Florida) whose
registrar address is (30 St Giles Street, Oxford, OX 1 3LE).

RECITALS:

(A)	Dr Gorbunov is the holder and beneficial owner of the
intellectual property related to the Bio Detection technologies
and part the holder and beneficial owner of the intellectual
property related to the Molecular Detection technologies.

(B)	Dr Gorbunov desires to grant to the Optionholder a call option in
respect of his intellectual property rights and shares in Company
A and Company B that will be or have already been formed for
these technologies.

NOW IT IS HEREBY AGREED as follows:

1.	DEFINITIONS AND INTERPRETATION

In this Agreement unless there is something in the subject or
context inconsistent therewith the following expressions have the
following meanings:

The Articles
means the articles of association
from time to time of Company A and
Company B;

Bio- Detection technologies

The COMPANY

means the Intellectual Property
Rights in relation to bio-detection
only

means the company which is purchasing
the option from company A and company
B

the Company(ies)
Means Company A and Company B or a
new company set up for the purpose of
conveying the IPR as referred to in
this document.

Company A
means a new company registered in
England  whose company number is
[4645054] and created to incorporate
the Bio- Detection technologies for
the purposes of this Agreement

Company B
means a new company registered in
England whose company number is
[4645054 ] and created to incorporate
the Molecular- Detection technologies
for the purposes of this Agreement

Completion
means the performance of both parties
obligations under Clause 3.2;

Encumbrance
means any charge, lien, equity, third
party right, option, right of pre-
emption or any other encumbrance,
priority or security interest of
whatsoever nature other than any such
arising under the Articles;

Exercise Date
means the date of service of an
Option Notice;

Intellectual Property
Rights
means patents, copyright, trade
marks, design rights, registered
designs, utility models, plant
variety rights, database rights,
rights in trade or business names,
semiconductor topography rights,
domain names, moral rights, rights in
performances, rights protecting
confidential information and know
how, rights protecting goodwill and
reputation and all similar or
analogous rights or forms of
protection anywhere in the world, and
all applications and rights to
register any of those rights;

"Bonus Price" milestone
The first positive "in-field" test of
a demonstration model of
Nucleation/Condensation transportable
detector or the first positive test
of Bio-product for the detection

The Milestone

A transportable
Nucleation/Condensation detector with
a performance capability higher than
any other competing products
currently available on the market
(known as InatSniffer)

Molecular Detection
technologies
means the Intellectual Property
Rights in relation to
Nucleation/Condensation technology
only (for the detection of dangerous
compounds in gaseous media known as
InatSniffer)

Option
means the option granted by Dr
Gorbunov to the Optionholder by this
Agreement pursuant to Clause 2.2;

Option Notice
means a notice exercising the Option
given pursuant to Clause 2.3;

Option Period
means the period commencing on the
date of this Agreement and expiring
at 5p.m. on the date falling 10 month
from the date of this Agreement (both
dates inclusive) only extendable by
the written agreement of Dr Gorbunov;

Option Shares
Means, separately, the total amount
of ordinary shares in the capital of
Company A and Company B held by Dr
Gorbunov at the date hereof and all
securities in  Company A and Company
B which are hereafter derived from
such shares or which are hereafter
distributed by Company A and Company
B in respect of such shares or any
securities previously so derived or
distributed and (in each case) of
which Dr Gorbunov is the beneficial
owner, or to which he is entitled,
from time to time together (if
applicable) with any ordinary shares
in the capital of Company A and
Company B acquired by Dr Gorbunov by
transfer from the other members of
Company A and Company B;

Reorganisation
means any variation in the issued
share capital of the Company A and
Company B whether by  way of
capitalisation issue, rights issue,
sub-division, consolidation,
reduction, purchase or otherwise or
any alteration of the rights attached
thereto;

Sale

A sale is the purchase of a single
unit of a product to a customer & the
payment being made according to
Federal accounting standard AcSEC
SOP98-4, SOP97-1, SOP97-2and SOP99-1

Technologies
The "Bio- Detection" and "Molecular
Detection" technologies;

Transfer Price
means the price to be paid (subject
to the satisfaction of certain
conditions as set out in Clause 4)
for the Option Shares which shall be
made up as follows:
(i)     2,000,000 pounds ("Initial Price")
(ii)    2,000,000 pounds ("Bonus Price")
(iii)   1,000,000 pounds ("Total Control
Price")
(iv)    2,000,000 pounds ("Bonus payment after
the first sale of the molecular
product")
(v)     2,000,000 pounds ("Bonus payment after
the first sale of either the bio
product, or the second sale of
the Nucleation/Condensation
product whichever event occurs
first

Transfer Terms
 means that all the Option Shares
shall be sold and purchased free from
any Encumbrance and together with all
rights attaching thereto as at the
Exercise Date (other than rights to
receive dividends which shall have
been paid prior thereto) or at any
time thereafter and that the
consideration for the Option Shares
shall be the Transfer Price.

1.2	Words importing persons shall be construed as importing a
corporate body and vice-versa
1.3	Where a party comprises more than one person the obligations and
liabilities of that party under this Agreement shall be joint and
several obligations and liabilities of those persons.
1.4	The clause headings do not form part of this Agreement and shall
not be taken in account in its construction or interpretation
1.5	Any reference to a clause or a paragraph or a schedule is to one
in this Agreement so numbered.

2.	CALL OPTION

2.1	In consideration of the Optionholder paying to Dr Gorbunov the
sum of 1 pound (receipt of which is hereby acknowledged), Dr Gorbunov
hereby grants to the Optionholder the option referred to in
Clause 2.2.

2.2	The Optionholder shall have the option to purchase all (but not
some only) of the Option Shares, on the exercise of which and in
accordance with this Agreement, Dr Gorbunov will become bound to
sell and the Optionholder will become bound to complete the
purchase of all of the Option Shares on the Transfer Terms.

2.3	The Option must be exercised by notice in writing to Dr Gorbunov
served only during the Option Period, failing which this
Agreement  will lapse and cease to have any further effect. An
Option Notice, once given, may not be withdrawn except with the
written consent of Dr Gorbunov.

2.4	If the Option is exercised, then the remaining provisions of this
Clause 2 and Clauses 3 and 5 will apply.

2.5	Neither Dr Gorbunov nor the Optionholder shall be obliged to
complete the sale and purchase of the Option Shares unless the
sale and purchase of all the Option Shares is completed
simultaneously, but completion of the sale and purchase of some
of the Option Shares will not affect the rights of Dr Gorbunov or
the Optionholder with respect to the other.

2.6	All voting and other rights attached to the Option Shares in
Company A and Company B shall accrue to the Optionholder on the
Completion Date and following that time Dr Gorbunov shall
exercise all voting and other rights at the direction of the
Optionholder if clause 5.7 is not in force. See Appendix A

3	COMPLETION

3.1	Completion of the sale and purchase of the Option Shares for
Company A and Company B shall take place at the registered
office of the Company (or at such other place as may be
agreed) at 12 noon on the day 14 days after the Exercise
Date, provided that if such day is not a business day then
Completion shall take place at 12 noon on the first business
day thereafter.

3.2	In relation to Company A and Company B On Completion, Dr
Gorbunov shall :

3.2.1	transfer or procure the transfer of the Option Shares
to the Optionholder;
3.2.2	deliver all relevant share certificates and other
documents of title in respect of the Option Shares to
the Optionholder;
3.2.3	account to the Optionholder for all benefits received
in respect of the Option Shares between the Exercise
Date and the date of Completion (both dates
inclusive);
3.2.4	deliver to the Optionholder any form of consent or
waiver required from Dr Gorbunov or any other member
of the Company to enable the transfer of the Option
Shares to be registered in accordance with the
Articles;
3.2.5	use his best endeavours to procure registration of the
transfer of the Option Shares forthwith (subject to
the transfer being stamped with any necessary stamp
duty at the expense of the Optionholder); and

3.2.6	do such things and execute such documents as shall be
necessary or as the Optionholder may reasonably
request to give effect to the sale of the Option
Shares on the Transfer Terms.

             3.3  In relation to Company A and Company B, the
Optionholder, shall on achieving the Bonus Price milestone,
pay the Bonus Price 2,000,000 pounds to Dr. Gorbunov in return for
Dr. Gorbunov effecting Completion of the Option Shares in
relation to Company A and Company B.

4	POST-SIGNING OBLIGATIONS OF DOCTOR GORBUNOV AND Optionholder

4.1	As soon as practicable after the execution of this
Agreement, Dr Gorbunuv shall procure that

4.1.1	all the Bio- Detection technologies owned by him are
assigned to, vested in and beneficially held by the
Company A; and,
4.1.2	all the Nucleation/Condensation technologies so far as
they owned only by him are assigned to, vested in and
beneficially held by the Company B.  In the case of
any part ownership in the Nucleation/Condensation
technologies Dr. Gorbunov will use his best endeavours
to procure that the Molecular- Detection technologies
are assigned to, vested in and beneficially held by
the Company A.

4.2	Dr Gorbunov undertakes that at the Exercise Date all his
Intellectual Property Rights in the Technologies shall be
owned by, vested in and beneficially held by the Companies
will be free from all encumbrances and any other third party
rights in accordance with clause 4.1 above .

4.3	As soon as practicable after the execution of this
Agreement, Dr Gorbunuv undertakes that he will use best
endeavours for and on behalf of the Optionholder to enter
into negotiations with all of the other members of the
Companies A & B for the purpose of entering into an binding
agreement to acquire all of their shares in these Companies
..

4.4	The Optionholder will after completion use its resources in
the best interest of all the Companies to commercially
exploit the IPR & Technologies concerned. The Optionholder
will not withhold reasonable resources to facilitate the
commercialisation of the acquired IPR as long as this will
not contravene US law.

5	PAYMENT OF THE TRANSFER PRICE

Subject to Dr Gorbunov complying with his obligations under
Clause 3, and on completion the Optionholder shall pay the
Transfer Price in accordance with the following provisions:

5.1	The Transfer Price shall be payable in cash provided that
the Optionholder may, at its option, satisfy up to a maximum
of fifty per cent (50%) of the Transfer Price by the
allotment and issue to Dr Gorbunov of such number of fully
tradable shares in the Optionholder as are of equal value
(determined at the Exercise Date) to that part of the
Transfer Price so satisfied as long as this action will not
contravene US securities exchange commission rules at the
time of the transaction.

5.2	The Optionholder shall pay the Initial Price on Completion
or (if later) the date falling 10 months after the
commencement of Dr Gorbunov's employment by the Company and
subject to Dr Gorbunov remaining an employee on that date.

5.3	If Dr Gorbunov shall have entered into a contract of
employment with the Optionholder in the form reasonably
acceptable to the Optionholder which requires that Dr
Gorbunov serve the Optionholder as an employee for a period
of not less than 10 months from the date of this Agreement
and meets the agreed "Bonus Price" milestone, the
Optionholder shall pay the Bonus Price on Completion or (if
later) the date falling 10 months after the commencement of
Dr Gorbunov's employment by the Company and subject to Dr
Gorbunov remaining an employee on that date.

5.4	If on Completion, the Option Shares represent the entire
issued share capital of Companies A and Company B, the
Optionholder shall immediately pay to Dr Gorbunov the Total
Control Price on Completion or (if later) the date falling
10 months after the commencement of Dr Gorbunov's employment
by the Company and subject to Dr Gorbunov remaining an
employee on that date.

..
5.5	on completion of the first sale of the
Nucleation/Condensation  product as referred to in the
definition of Transfer Price in clause 1 and that uses the
technologies, Dr Gorbunov is to be immediately paid
2,000,000 pounds as in clause 5.1

5.6	On Completion of the first sale of a bio product as referred
to in the definition of Transfer Price in clause 1 and that
uses the Bio- Detection technologies or on the sale of a
second molecular product that uses the Molecular- Detection
technologies, whichever is the first event, the Optionholder
shall immediately pay to Dr Gorbunov the sum of 2,000,000 pounds
as in clause 5.1.

5.7	Should Optionholder fail to meet the payment schedule any
IPR , share certificates and other documents of title in
respect of Option Shares held by the Optionholder in either
Company A or Company B will be returned to Dr Gorbunov.
Monies (both cash and shares) paid for shares and IPR in
Company A and Company B as in the Transfer price (ii) will
be returned to the Company. Monies (both cash and shares)
paid as in the Transfer price (i) and (iii) to Dr Gorbunov
will remain with Dr Gorbunov. Each party will be fully
responsible for their own taxation liabilities.

6	OWNERSHIP AND ALIENATION

6.1	Dr Gorbunov warrants to the Optionholder that at the time of
execution of this Agreement he is the registered holder and
beneficial owner of the Option Shares and that, apart from
this Agreement, such shares are free from all Encumbrances
and that he has full power and authority to exercise and
enjoy all rights attaching thereto without the consent of
any other person and to grant the Option in respect of the
same upon the terms and conditions of this Agreement.

6.2	Dr Gorbunov undertakes to the Optionholder that during the
Option Period he will not (without the prior written consent
of the Optionholder) dispose of any interest in any of the
Option Shares or any right attaching thereto (save as may be
required in pursuance of his obligations under this
Agreement) or create or allow to be created any Encumbrance
over any of the Option Shares or agree (whether subject to
any condition precedent or condition subsequent or
otherwise) to do any of such things.

7	DURATION OF OBLIGATIONS

7.1	Agreement shall terminate on the expiry of the Option Period
if no Option Notice shall have been served on or prior to
such date.

7.2	If an Option Notice shall have been served on or prior to
the date mentioned in Clause 7.1  this Agreement shall
continue in force after such date until the fulfilment of
the parties' obligations hereunder in relation to such
Option Notice whereupon it shall terminate.

8	REORGANISATIONS

8.1	Dr Gorbunov shall procure that until this Agreement
terminates in accordance with Clause 7 the Company A and
Company B shall not effect any Reorganisation without the
prior written consent of the Optionholder.

8.2	Dr Gorbunov shall procure that until this Agreement
terminates in accordance with Clause 7 that Company A and
Company B shall not issue, allot, redeem, purchase or grant
options over any of its shares or other securities nor issue
or create any loan or other security convertible into its
shares.

9	CONFIDENTIALITY

This Clause contains restrictions on the use of information
disclosed by either party ("the Disclosing Party") to the other
("the Receiving Party").

9.1	Definitions.

For the purposes of this clause 9 the following expressions shall
have the following meanings:

9.1.1	"Confidential Information" means:
(a)	All information of a confidential nature or which
is marked or identified as confidential at the
time of disclosure, which is provided directly or
indirectly by the Disclosing Party to the
Receiving Party  (in any form or stored on any
medium), and whether before, on or after the date
of this Agreement;

(b)	any copy of any of the information described in
paragraph (a) above including a version of that
information incorporated in another form; and

(c)	the fact that discussions are taking place
between us the parties to this Agreement and the
terms of this Agreement.

9.1.2	"The Purpose" means negotiations for the exploitation
of the Technologies.

9.2	Confidentiality and Non-Use

The Receiving Party undertakes to the Disclosing Party to keep the
Confidential Information secret at all times, not to disclose it or
allow it to be disclosed in whole or in part to any third party
without the Disclosing Party's prior written consent and not to use
all or any of it except for the Purpose.

Exceptions.

A party will not breach this the obligations in Clause 9.2 hereof
to the extent that the Confidential Information which is
disclosed:

9.2.1	is known to the Receiving Party before its disclosure
by the Disclosing Party; or

9.2.2	is or becomes publicly known without the fault of the
Receiving Party; or

9.2.3	is obtained by the Receiving Party from a third party
in circumstances where the Receiving Party has no
reason to believe that there has been a breach of an
obligation of confidentiality owed to the Disclosing
Party; or

9.2.3.1	is independently developed by the Receiving
Party; or where. Party  such development is
not either a consequence, directly or
indirectly, of access to the Intellectual
Property Rights; or,
9.2.3.2	by way of reverse engineering;

9.2.4	is approved for release in writing by an authorised
representative of the Disclosing Party; or

9.2.5	is required to be disclosed pursuant to an order of
any Court of competent jurisdiction; or

9.2.6	is required to be disclosed for the purpose of
obtaining legal advice

9.3	Permitted disclosures by the Optionholder

The Optionholder undertakes to permit access to Dr Gorbunov's
Confidential Information only to those third parties (including,
but not limited to, potential investors in the Technologies) who
reasonably need access to Dr Gorbunov's Confidential Information
for the Purpose, and on the condition that those third parties
must have:

9.3.1	those third parties must have entered into legally
binding confidentiality obligations with the Receiving
Party and the Disclosing Party on terms equivalent to
those set out in this Agreement and applicable to the
Confidential Information;

9.3.2	those third parties must have been informed of the
Disclosing Party's interest in the Confidential
Information and the terms of this Agreement; and

9.3.3	those third parties must have been instructed to treat
the Confidential Information as secret and
confidential in accordance with the provisions of this
Agreement.

9.3.4	the Optionholder shall:

9.3.4.1	obtain a full indemnity from each of the third
parties in respect of a breach of
confidentiality; and,
9.3.4.2	will fully indemnify and keep indemnified Dr.
Gorbunov, for any unauthorised disclosure of
Confidential Information by any third party
who had Confidential Information disclosed to
them by the Optionholder

9.7	Return of information and property

The Receiving Party acknowledges and agrees that the property and
copyright in Confidential Information disclosed to it by the
Disclosing Party, including any documents, files and other items
containing any Confidential Information or in any other form of
media, belongs to the Disclosing Party.  At the Disclosing
Party's written request, the Receiving Party will return
immediately to the Disclosing Party all Confidential Information
which the Receiving Party has received under this Agreement and
which whether or not the information is in the Receiving Party's
possession, including any copies made in any other form of media,
and make no further use or disclosure of any of the Confidential
Information.

9.8       No implied rights

	9.8.1 This Agreement is not intended to grant the Receiving Party
any license or rights howsoever arising in respect of the
Confidential Information other than as expressly set out in
this Agreement nor to require the Disclosing Party to
disclose any Confidential Information to the Receiving Party.

9.8.2	No warranty, condition or representation, express or
implied, is given as to the accuracy, efficacy, completeness,
capabilities or safety of any materials or information
provided under this Agreement.

9.9	Press releases, etc

Neither party will issue any press release or similar statement
or give any interview to the media relating to the Purpose
without first obtaining the other party's consent.

10  EXCLUSIVITY

In consideration of the Optionholder paying to Dr Gorbunov the
sum of 1 pounds receipt of which is hereby acknowledged, Dr Gorbunov
agrees that he shall not (and shall procure that Company A and
Company B shall not,) during the Option Period negotiate with any
party other than the Optionholder for the use or exploitation in
any way of all or any part of the Technologies or transfer or
grant any rights in or to all or any part of the Technologies to
any third party, and the Optionholder is hereby granted sole and
exclusive rights to market, [sell], produce, [distribute] and
otherwise exploit during the Option Period the Technologies and
any products arising from or derived or created from the
Technologies.

11 NOTICES

Any notice required or permitted to be given hereunder shall be
in writing and shall be sent to the relevant party at their
address for service in England and Wales as set out in this
Agreement or to such other address in England as they may
designate by notice to the other party in accordance with this
Clause. Any such notice shall be delivered personally or sent in
a pre-paid letter and shall be deemed to have been served if by
personal delivery when delivered and if by post 48 hours after
posting.

12 GENERAL

12.1	This Agreement may not be assigned in whole or in part but
is binding upon and shall inure for the benefit of the
parties' personal representatives and other successors.

12.2	This Agreement shall be governed by and construed in
accordance with the laws of England and the parties hereby
submit to the non-exclusive jurisdiction of the English
Courts.

12.3	The parties hereto shall, and shall use their respective
best endeavours to procure that any necessary third parties
shall, execute and do all such further deeds, documents and
things as either party may reasonably require by notice in
writing to the other party to carry the provisions of this
Agreement into full force and effect and (so far as they are
able) shall do everything necessary (including, without
limitation, exercising their powers as shareholders and as
directors of the Company) to give effect to the spirit and
intent of this Agreement.

EXECUTED as a deed the day and year first before written.

SIGNED as a DEED and DELIVERED by	)   /s/ Boris Gurbanov
BORIS GURBANOV in the presence of:	)

Witness Signature		. /s/ Ranjit Sodhi

Witness Name		...Ranjit Sodhi.

Witness Address		.20 salam road Stevenage
				.Hertfordshire SQ1 13H.

Witness Occupation		.Consultant.....

SIGNED and DELIVERED by	/s/ Terence Sullivan
Terence Sullivan			............

and Greg Chan on behalf 	  	............
of The COMPANY  and thereby
executed by it as its DEED

...President  Terence Sullivan.
[Title of authorised signatory]

..Company Secretary. Greg Chan.
[Title of authorised signatory]

EXECUTED as a deed the 8th day February 2004

SIGNED as a DEED and DELIVERED by )  /s/ Boris Gorbunov
BORIS GURBANOV in the presence of:)

Witness Signature                      . /s/ Olga Gorbunov......

Witness Name                            .Olga Gorbunov......

Witness address                          .20 kings Park......

                                                    ..Canterbury CT1
1QH....

Witnessed Occupation                .Student.....

SINED And DELIVERED by
Terence Sullivan                          ....... /s/ Terence Sullivan

President Terence Sullivan
{Title of autherised signatory}

Company Secretary Gregory Chan
{ Title of Authorised signatory}

Witness Sinature                                    .. /s/ Janet
Sullivan......

Witness Name                                        . Janet
Sullivan.....

Withness Address                                   .Glyme
House..................
                                                                 .St
John Street, Bicester, Oxon....
Witness Occupation                                ..Medical E. P.
A....

Appendix A

Dr Boris Gorbunov by signing this document attests that he holds free
from all Encumbrance .92% in company A
The Share percentages in Company A are as follows:
Name		Dr Boris Gorbunov .......92%
Name		Middlesex University ......08%
Name		.................%
Name		.................%
Name		.................%

Dr Boris Gorbunov by signing this document attests that he holds free
from all Encumbrance .92% in company B
The Share percentages in Company B are as follows:
Name		Dr Boris Gorbunov   ......92.0%
Name		Middlesex University   .....08.0%
Name		.................%
Name		.................%
Name		.................%

EXECUTED as a deed the day and year first before written.

22/Feburary/2004
SIGNED by Mr Terrence Sullivan (on behalf and for ASI)....
/s/ Terence Sullivan

SIGNED by Dr Boris Gurbunov .
22/February 2004  /s/ Boris GorbunovThis Addendum to the Financing Agreements between Citywide
Management Services, Inc. ("Citywide") and Atlantic Security,
Inc. (the "Company") is entered into this 2nd day of November
2004.

RECITALS

WHEREAS, Citywide has committed to purchase from the Company a
total of $5,500,000 worth of shares of the Company's common stock
pursuant to Regulation S of the Securities Act of 1933, as
amended; and

WHEREAS, the Company has requested and Citywide has agreed to the
restriction set forth herein regarding various activities; and

NOW THEREFORE, in consideration of the agreements and terms
contained herein, and for other valuable consideration, receipt
and sufficiency of which is hereby mutually acknowledged, the
Parties hereto, intending to be legally bound, agree as follows:

1)	Citywide, together with its affiliates, will not purchase
securities of the Company that would result in Citywide,
together with its affiliates, beneficially owning in excess
of 4.99% of the number of the Company's shares of common
stock outstanding at that time.

2)	This Agreement may be executed as of the same effective
date in one or more counterparts, each of which shall be
deemed an original.

3)	This Agreement serves as an addendum to, and not a
replacement of, the Financing Agreements previously entered
into by and between the parties.

Atlantic Security, Inc.                  Citywide Management Services, Inc.

/s/ Terence Sullivan                     /s/ P. Lorathern
--------------------                     ------------------------------
By: Terence Sullivan                     By: P. Lorathern
Its: President                           Its: authorized signatory

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00074-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00074-of-00352.parquet"}]]